GR Life Style Company Limited held its Annual General Meeting on 26 June 2026, with all seven resolutions receiving decisive shareholder support via poll voting.

• Capital base and quorum: The meeting covered 3.32 billion issued shares, each entitled to vote; no share class carried voting restrictions or required abstention under Hong Kong Listing Rules.

• Financial statements: Adoption of the 2025 audited consolidated accounts and accompanying directors’ and auditor’s reports garnered 1.91 billion votes in favour, representing 99.99 % approval.

• Board composition and remuneration: – Executive directors Wei Chunxian, Wei Laier and Sun Zhongmin were each re-elected with 99.99 % support (≈1.91 billion votes). – Independent non-executive director Tung Woon Cheung Eric was re-appointed with 99.99 % backing. – Authorisation for the Board to set directors’ remuneration passed with the same 99.99 % approval level.

• Auditor: BDO Limited was appointed for the next financial year, securing 1.90 billion votes (99.65 %) versus 6.63 million against.

• General mandates: – Issuance/allotment of shares or disposal of treasury shares: 99.65 % approval. – Share repurchase authority: 99.99 % approval. – Extension of the issue mandate to include repurchased shares: 99.65 % approval.

• Corporate rebranding (special resolution): Shareholders endorsed changing the company’s English name to “SR Medical Technology Company Limited” and the Chinese name to “春雨醫療科技有限公司”, with 1.91 billion votes (99.99 %) in favour—well above the 75 % threshold for special resolutions.

All six directors—Wei Chunxian, Wei Laier, Sun Zhongmin, Tung Woon Cheung Eric, To Tsz Wan Vivien and Leung Louis Ho Ming—were present at the meeting. Tricor Investor Services Limited acted as the independent scrutineer for vote-counting.

The comprehensive approval of operational mandates, board appointments and the forthcoming name change positions the company for its next phase under the SR Medical Technology brand.